Rani Therapeutics Holdings Inc (RANI) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Rani Therapeutics Holdings Inc   (NASDAQ: RANI)

Rani Therapeutics Holdings Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RANI Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 67.76 % 64.81 % 46.17 %
Gross Margin (Q2 TTM) 0 % 69.77 % 63.91 % 45.96 %
Gross Profit Margin 5 Yr. Avg. - 68.59 % 65.27 % 47.54 %
EBITDA Margin (Q2 MRQ) 14.75 % 24.1 % 21.69 % 20.81 %
EBITDA Margin (Q2 TTM) -125.98 % 25.3 % 20.74 % 19.32 %
EBITDA Margin 5 Yr. Avg. - 34.48 % 25.84 % 21.86 %
Operating Margin (Q2 MRQ) -516.86 % 19.68 % 18.32 % 15.88 %
Operating Margin (Q2 TTM) -675.8 % 18.91 % 16.39 % 15.55 %
Operating Margin 5 Yr. Avg. - 13.96 % 13.31 % 16.97 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 17.28 % 14.29 % 13.29 %
Pre-Tax Profit Margin (Q2 TTM) -162.27 % 16.78 % 12.44 % 12.41 %
Pre-Tax Profit Margin 5 Yr. Avg. - 11.99 % 9.87 % 11.9 %
Net Margin (Q2 MRQ) -493.03 % 13.16 % 10.78 % 10.26 %
Net Margin (Q2 TTM) -685.34 % 15.04 % 10.56 % 10.03 %
Net Margin 5 Yr. Avg. - 7.73 % 7.17 % 9.59 %